Found: 4
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 24–33
Lapkina E.Z., Zinchenko I.S., Bondar Е.I., Ruksha T.G.
Introduction. Cancer drug resistance is driven among others, by non-genetic mechanisms. These processes may involve transcription factors dysregulation, modifications in gene expression, as well as epigenetic mechanisms such as DNA methylation, histone modific…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 38–44
Lapkina E.Z., Kutsenko V.A., Ruksha T.G.
Introduction. Cancer cell drug resistance in melanoma is associated with evasion of apoptosis-induced stimuli. Assessing the level of expression of the BCL2 and SIRT1 genes in distant organs and the tumor node makes it possible to assess the resistance of mela…
ОБЗОР2016
Poveshchenko A.F., Poveshchenko O.V., Solovieva A.O., Zubareva K.E., Miller T.V., Shestopalov M.A., Shundrin L.A., Konenkov V.I.
Review is devoted to systems for drug delivery of biologically active substances in the tissues and organs of the target cells, which is relevant to medicine. There are described properties of mesenchymal stromal cells (MSCs), which many authors propose to use…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Bandovkina V.A., Frantsiyants E.M., Pogorelova Yu.A., Cheryarina N.D.
Introduction. Hormonal aspect in the pathogenesis of melanoma development is still poorly studied. Tumor transplantation to experimental animals allows to study the effect of malignant process on different systems and organs, detect the saturation of tumor and…